🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

One month to go until our #GoingForGold awards ceremony 🏅 With 24 medals up for grabs across 8 categories relating to healthy ageing, who do you think will win gold? Join us and Int Longevity Centre in Paris on 16 July to see who wins 👇️ ilcuk.org.uk/going-for-gold…

🔜 Just 2 weeks to go! Michèle Le Goff, Chair of AGE's Task Force on Dignified and #HealthyAgeing, will speak at the #GoingForGold awards ceremony in Paris, organised by the Int Longevity Centre The ILC Europe Network 📅 Tuesday, 16 July 📍 Paris, France 📝 ilcuk.org.uk/going-for-gold… Don't miss out!

🇰🇷 "Korea should strengthen policy support for adult immunization amid rapid population aging." Earlier this week, Int Longevity Centre Chief Executive David Sinclair spoke at the 2024 Healthy Ageing Korea forum in Seoul organised by UK in Korea🇬🇧🇰🇷 & GSK 👇 koreabiomed.com/news/articleVi…

Join VaccinesEurope later today for a multistakeholder discussion on the value of #prevention and #immunisation 👇

A recent report from Int Longevity Centre, shows that while only 21% of #EU citizens report low levels of trust in their country’s healthcare system, this figure is 49% across parts of Eastern Europe. Learn more 👇 #InformAndProtect vaccinestoday.eu/stories/why-is…

Vaccination rates in Central and Eastern European countries are lower than in some western European countries, particularly for #vaccines that protect adolescents and adults. Find out more 👇👇 #InformAndProtect #europe Int Longevity Centre vaccinestoday.eu/stories/why-is…

Follow the ILC Europe Network on LinkedIn!👇 linkedin.com/company/ilc-eu…

At least 1.6 million lives saved so far in the WHO/Europe Region thanks to #COVID19 vaccines among mainly older adults. Our new publication in The Lancet Respiratory Medicine highlights the crucial role of vaccination amid the pandemic. But #COVID19 is ‘not over’. 🔗 bit.ly/3YCCaPR

Take a look at the latest Int Longevity Centre report on the value of life course immunisation. Every $1 spent on adult immunisation can generate socioeconomic returns of $19. #VaccinesWork

As the world grapples with current and emerging health challenges, life-course immunisation remains a highly cost-effective public health intervention. Adopting a prevention-first mindset towards health is essential bit.ly/4b0is3y #VaccinesForLife #WeWontRest

With the #Olympics now finished, VaccinesToday takes a look at the Int Longevity Centre #GoingForGold report to see who would win medals for immunisation 👇

Immunisation has long been celebrated as one of the most cost-effective public health interventions. However, its value extends beyond just protecting individuals from disease. Hyderus explores Int Longevity Centre's new research 👇 hyderus.com/the-economic-a…

Join us on 15th October for the Immunisation for Life joint international conference co-organised with The Association of Innovative Pharmaceutical Manufacturers to discuss life-long immunisation and pharmacy-based vaccination with experts in the field bit.ly/3TzAGlX

In 2009, the Council called for 75% uptake for #flu vaccination. Since then, Europe has faced #COVID19 & a surge in #RSV reinforcing the value of: 🔵Harmonised & timely data 🔵Electronic vaccination registries in all MS Join the conversation at #EUFluDay eventbrite.com/e/eu-flu-day-2…

The Int Longevity Centre has published a new report to put the spotlight on the critical role of #immunisation throughout our lives. 👇Read now how finance ministers can shape future investments in vaccination for all 👇 vaccinestoday.eu/stories/financ…

Today is #EUFluDay 🇪🇺 15 years on from setting the 75% flu vaccination target, European countries still struggle to meet this goal. How do we improve uptake? Join the debate today 👇 eventbrite.com/e/eu-flu-day-2… VaccinesToday VaccinesEurope Acumen Public Affairs

💡Prevention and #vaccines help tackling infectious diseases, #NCDs and #AMR. ✍ In their latest article for Euractiv, IFPMA 's Bigger Laetitia & VaccinesEurope's sibilia quilici call for a paradigm shift towards prevention-based healthcare models ⤵️ euractiv.com/section/health…

Shingles affects 1 in 3 adults aged 50+ according to Int Longevity Centre research. Age UK also highlights the risk between #shingles and dementia in HuffPost 👇 huffingtonpost.co.uk/entry/dementia…

New VaccinesEurope report on the 2024 vaccines pipeline - still a large focus on #COVID19 and #flu but some interesting developments this past year 👇 vaccineseurope.eu/vaccines-ecosy…

In an ageing society, immunosenescence is likely to impact adult #vaccination How can we address immunosenescence and improve immunisation programmes in Europe? Find out more about our latest project with Int Longevity Centre The ILC Europe Network 👇 ilcuk.org.uk/supporting-our…